{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:59:46Z","timestamp":1791197986746,"version":"4.1.0"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006595","name":"Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii","doi-asserted-by":"publisher","award":["23.16.01.03"],"award-info":[{"award-number":["23.16.01.03"]}],"id":[{"id":"10.13039\/501100006595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018987","name":"Ministerul Cercetarii, Inovarii \u015fi Digitalizarii","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018987","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cutaneous melanoma remains one of the most challenging neoplasms and the deadliest form of skin cancer. miRNAs are a class of non-coding RNA molecules found in both tissues and body fluids that can negatively regulate gene expression in eukaryotic cells, playing key roles in health and disease. Dysregulated miRNA levels have been linked to various aspects of melanocytic tumor biology, including the transition from benign to malignant stages, immunosuppression, dissemination, and therapy resistance. Here, we provide a timely review of the roles of miRNAs within the cutaneous melanoma tumor microenvironment, emphasizing their impact on immune cell phenotypes and functions, angiogenesis, innate and adaptive immunity, and immune checkpoint expression to help refine future biomarkers and therapeutic targets in the field. We will also address their roles in circular and long non-coding RNA sponging interactions and the potential for translating miRNAs into clinical practice, given their simultaneous presence in both cutaneous melanoma tissues and liquid biopsies. The main challenges and limitations associated with such a translational approach will also be addressed.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1949578","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:03:52Z","timestamp":1791194632000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["miRNAs bridging the gap between the tumor microenvironment and liquid biopsy in cutaneous melanoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Monica","family":"Neagu","sequence":"first","affiliation":[{"name":"Immunology Laboratory, \u201cVictor Babe\u015f\u201d National Institute of Pathology","place":["Bucharest, Romania"]},{"name":"Department of Pathology, Colentina Clinical Hospital","place":["Bucharest, Romania"]},{"name":"Doctoral School, Faculty of Biology, University of Bucharest","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena-Georgiana","family":"Dobre","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, \u201cVictor Babe\u015f\u201d National Institute of Pathology","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Constantin","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, \u201cVictor Babe\u015f\u201d National Institute of Pathology","place":["Bucharest, Romania"]},{"name":"Department of Pathology, Colentina Clinical Hospital","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060903","article-title":"Current perspectives on the role of matrix metalloproteinases in the pathogenesis of basal cell carcinoma","volume":"11","author":"Tampa","year":"2021","journal-title":"Biomolecules"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00071","article-title":"miRNAs in the diagnosis and prognosis of skin cancer","volume":"8","author":"Neagu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/genes10010052","article-title":"Epitranscriptomic signatures in lncRNAs and their possible roles in cancer","volume":"10","author":"Dinescu","year":"2019","journal-title":"Genes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2026.120903","article-title":"Multi-omic biomarker detection in UV-induced melanoma","volume":"585","author":"Alqahtani","year":"2026","journal-title":"Clin Chim Acta"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153942","article-title":"Dysplastic nevi and melanoma: microRNAs tell a divergent story","volume":"235","author":"Durante","year":"2022","journal-title":"Pathol Res Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2025.15350","article-title":"m6A RNA methylation regulator-associated genes drive metastasis and immune cell infiltration in skin cutaneous melanoma","volume":"30","author":"Geng","year":"2025","journal-title":"Oncol Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14131450","article-title":"Synthesis and regulation of miRNA, its role in oncogenesis, and its association with colorectal cancer progression, diagnosis, and prognosis","volume":"14","author":"Rac","year":"2024","journal-title":"Diagnostics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1159\/000524283","article-title":"Reference genes for qPCR-based miRNA expression profiling in 14 human tissues","volume":"31","author":"Veryaskina","year":"2022","journal-title":"Med Princ Pract"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108466","article-title":"Noncoding RNA circuitry in melanoma onset, plasticity, and therapeutic response","volume":"248","author":"Grafanaki","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70367","article-title":"Diagnostic power of microRNAs in melanoma: integrating machine learning for enhanced accuracy and pathway analysis","volume":"29","author":"Rafiepoor","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12920-024-02028-w","article-title":"RNA-seq validation of microRNA expression signatures for precision melanoma diagnosis and prognostic stratification","volume":"17","author":"Love","year":"2024","journal-title":"BMC Med Genomics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcskn.2026.101127","article-title":"Validation of a prognostic microRNA signature in early-stage melanoma across NanoString and RNA-sequencing platforms","volume":"4","author":"Van Laar","year":"2026","journal-title":"EJC Skin Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211504","article-title":"Characterisation and validation of Mel38; A multi-tissue microRNA signature of cutaneous melanoma","volume":"14","author":"Van Laar","year":"2019","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28447","article-title":"Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment","volume":"14","author":"Feichtenschlager","year":"2023","journal-title":"Oncotarget"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13862","article-title":"Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11564","article-title":"Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22","volume":"7","author":"Luan","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/cad.0000000000001390","article-title":"LncRNA MSC-AS1, as an oncogene in melanoma, promotes the proliferation and glutaminolysis by regulating the miR-330-3p\/YAP1 axis","volume":"33","author":"Tian","year":"2022","journal-title":"Anticancer Drugs"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2174\/1871520621666210322092906","article-title":"The lncRNA MIR155HG is upregulated by SP1 in melanoma cells and drives melanoma progression via modulating the miR-485-3p\/PSIP1 axis","volume":"22","author":"Huo","year":"2021","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000803","article-title":"LINC01063 functions as an oncogene in melanoma through regulation of miR-5194-mediated SOX12 expression","volume":"32","author":"Xu","year":"2022","journal-title":"Melanoma Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-021-00313-9","article-title":"Long noncoding RNA LINC01291 promotes the aggressive properties of melanoma by functioning as a competing endogenous RNA for microRNA-625-5p and subsequently increasing IGF-1R expression","volume":"29","author":"Wu","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"44395","DOI":"10.1038\/s41598-025-28087-2","article-title":"LINC01116 promotes nascent protein synthesis and cellular stemness through the miR-432-5p\/FKBP7\/14 regulatory axis in melanoma","volume":"15","author":"Sun","year":"2025","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2174\/1386207326666230816113411","article-title":"LncRNA LINC00847 accelerates melanoma progression by regulating miR-133a-3p\/TGFBR1 axis","volume":"27","author":"Jiang","year":"2024","journal-title":"Comb Chem High Throughput Screen"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.84072","article-title":"LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the \u03b2-catenin signaling pathway","volume":"21","author":"Luo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204413","article-title":"LINC01296 promotes proliferation of cutaneous malignant melanoma by regulating miR-324-3p\/MAPK1 axis","volume":"15","author":"Wang","year":"2022","journal-title":"Aging"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_5746","article-title":"LINC00518 affects the proliferation, invasion and migration of cutaneous malignant melanoma cells via miR-526b-3p\/EIF5A2 axis","volume":"69","author":"Xu","year":"2022","journal-title":"Acta Biochim Pol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/kjm2.12467","article-title":"LINC01224 facilitates the proliferation and inhibits the radiosensitivity of melanoma cells through the miR\u2010193a\u20105p\/NR1D2 axis","volume":"38","author":"Cui","year":"2021","journal-title":"Kaohsiung J Med Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23687","article-title":"KCNQ1OT1 sponges miR\u201034a to promote malignant progression of malignant melanoma via upregulation of the STAT3\/PD\u2010L1 axis","volume":"38","author":"Wang","year":"2022","journal-title":"Environ Toxicol"},{"key":"B28","article-title":"LncRNA HCG18 facilitates melanoma progression by modulating miR-324-5p\/CDK16 axis","volume":"14","author":"Zhang","year":"2022","journal-title":"Am J Transl Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/jca.81723","article-title":"LncRNA DANCR enhances angiogenesis to promote melanoma progression via sponging miR-5194","volume":"14","author":"Jia","year":"2023","journal-title":"J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2034586","article-title":"YY1-induced long non-coding RNA small nucleolar RNA host gene 8 promotes the tumorigenesis of melanoma via the microRNA-656-3p\/SERPINE1 mRNA binding protein 1 axis","volume":"13","author":"Shan","year":"2022","journal-title":"Bioengineered"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19284","article-title":"Long non-coding RNA CYTOR promotes the progression of melanoma via the miR-485-5p\/GPI axis","volume":"13","author":"Lu","year":"2025","journal-title":"PeerJ"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04515-z","article-title":"Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208\/SOX4","volume":"478","author":"Yang","year":"2022","journal-title":"Mol Cell Biochem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10565-024-09851-y","article-title":"Circular RNA circFCHO2(hsa_circ_0002490) promotes the proliferation of melanoma by directly binding to DND1","volume":"40","author":"Yang","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.14670\/HH-18-622","article-title":"CircRTTN upregulates EPHA2 to aggravate the malignant process of melanoma via sponging miR-890","volume":"39","author":"Wang","year":"2024","journal-title":"Histol Histopathol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2174\/1871520623666230609163916","article-title":"CircFAT1 promotes the proliferation and invasion of malignant melanoma through miR375-SLC7A11 signal axis","volume":"23","author":"Lu","year":"2023","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2022.2072636","article-title":"Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661\/RAB3D","volume":"21","author":"Lin","year":"2022","journal-title":"Cell Cycle"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0287347","article-title":"Exosome-delivered circRPS5 inhibits the progression of melanoma via regulating the miR-151a\/NPTX1 axis","volume":"18","author":"Zhu","year":"2023","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4627","article-title":"circITCH suppresses cell proliferation and metastasis through miR\u2010660\/TFCP2 pathway in melanoma","volume":"11","author":"Zhang","year":"2022","journal-title":"Cancer Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/bjd\/ljad137","article-title":"Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma","volume":"189","author":"Van Laar","year":"2023","journal-title":"Br J Dermatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.477","article-title":"Development and validation of a plasma-based melanoma biomarker suitable for clinical use","volume":"118","author":"Van Laar","year":"2018","journal-title":"Br J Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35317-3","article-title":"Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival","volume":"8","author":"S\u00e1nchez-Sendra","year":"2018","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061532","article-title":"The prognostic value of miR-125b, miR-200c and miR-205 in primary cutaneous malignant melanoma is independent of Braf mutational status","volume":"14","author":"S\u00e1nchez-Sendra","year":"2022","journal-title":"Cancers"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s13577-020-00473-0","article-title":"Comprehensive upstream and downstream regulatory analyses identify miR-675-3p as a potential prognostic biomarker in melanoma","volume":"34","author":"Zhao","year":"2021","journal-title":"Hum Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13566","article-title":"MiRNAs as potential prognostic biomarkers for metastasis in thin and thick primary cutaneous melanomas","volume":"39","author":"Valentini","year":"2019","journal-title":"Anticancer Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.039","article-title":"MiR-200a regulates CDK4\/6 inhibitor effect by targeting CDK6 in metastatic melanoma","volume":"137","author":"Bustos","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.09.654","article-title":"Expression patterns of microRNAs and associated target genes in ulcerated primary cutaneous melanoma","volume":"143","author":"DiVincenzo","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-24-3785","article-title":"Tumor miRNA signatures associate with outcomes of patients with stage II\/III melanoma","volume":"31","author":"Wiggins","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133224","article-title":"Oxidative-stress-sensitive microRNAs in UV-promoted development of melanoma","volume":"14","author":"Pecorelli","year":"2022","journal-title":"Cancers"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061205","article-title":"MicroRNA-155 and disease-related immunohistochemical parameters in cutaneous melanoma","volume":"13","author":"Fawzy","year":"2023","journal-title":"Diagnostics"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16010051","article-title":"MicroRNAs as diagnostic and prognostic biomarkers in melanoma and non-melanoma skin cancers: an updated review","volume":"16","author":"Oiegar","year":"2025","journal-title":"Diagnostics"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.07.016","article-title":"Therapeutic strategies for targeting CDKN2A loss in melanoma","volume":"143","author":"Kreuger","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02285-0","article-title":"Down-regulated expression of miR-582 predicts poor prognosis and facilitates melanoma progression by targeting FOXC1","volume":"314","author":"Chen","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28591","article-title":"When does a melanoma metastasize? Implications for management","volume":"15","author":"Thompson","year":"2024","journal-title":"Oncotarget"},{"key":"B54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and metastasis in cancer: molecular insights and therapeutic targets","volume":"10","author":"Li","year":"2025","journal-title":"Sig Transduct Target Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.852952","article-title":"In vivo miRNA decoy screen reveals miR-124a as a suppressor of melanoma metastasis","volume":"12","author":"Moubarak","year":"2022","journal-title":"Front Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21873\/cgp.20361","article-title":"Small RNA sequencing identifies a six-microRNA signature enabling classification of brain metastases according to their origin","volume":"20","author":"Roskova","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113350","article-title":"Brain metastasis from unknown primary tumour: moving from old retrospective studies to clinical trials on targeted agents","volume":"12","author":"Balestrino","year":"2020","journal-title":"Cancers"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41598-025-31344-z","article-title":"Circulating microRNAs do not provide a diagnostic benefit over tissue biopsy in patients with brain metastases","volume":"16","author":"Ruckova","year":"2025","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910859","article-title":"The expression of miR-211-5p in sentinel lymph node metastases of malignant melanoma is a potential marker for poor prognosis","volume":"25","author":"Moritz","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21203\/rs.3.rs-1013292\/v1","article-title":"Identification of TUBB4A as a prognostic biomarker of melanoma by transcriptomic data and in vitro experiments","volume":"22","author":"Zhang","year":"2023","journal-title":"Technol Cancer Res Treat"},{"key":"B61","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2174\/1389201023666220928120902","article-title":"Dysregulation of SNHG16(lncRNA)-hsa-let-7b-5p(miRNA)-TUBB4A (mRNA) pathway fuels progression of skin cutaneous melanoma","volume":"23","author":"Chen","year":"2022","journal-title":"Curr Protein Pept Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2174\/1386207324666210816121833","article-title":"Integrated analysis of the expression, involved functions, and regulatory network of RUNX3 in melanoma","volume":"25","author":"Feng","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"key":"B63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-026-00425-4","article-title":"BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations","volume":"7","author":"Shang","year":"2026","journal-title":"Mol BioMed"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cimb48030279","article-title":"Upregulation of miR-4286 and miR-146a-5p in metastatic melanoma, revealed by multiplex expression analysis","volume":"48","author":"Pochileev","year":"2026","journal-title":"Curr Issues Mol Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000692","article-title":"Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma","volume":"30","author":"DiVincenzo","year":"2020","journal-title":"Melanoma Res"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00675","article-title":"Ras-induced miR-146a and 193a target Jmjd6 to regulate melanoma progression","volume":"9","author":"Anelli","year":"2018","journal-title":"Front Genet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12967-024-05527-7","article-title":"miR-876-3p is a tumor suppressor on 9p21 that is inactivated in melanoma and targets ERK","volume":"22","author":"Bezrookove","year":"2024","journal-title":"J Transl Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154772","article-title":"miR-224\u20135p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway","volume":"249","author":"Liu","year":"2023","journal-title":"Pathol Res Pract"},{"key":"B69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00210-024-03366-3","article-title":"Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential","volume":"398","author":"Afsar","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70386","article-title":"Targeting the microbiota-miRNA-protease axis: A new therapeutic avenue in melanoma","volume":"293","author":"Katsoulieris","year":"2026","journal-title":"FEBS J"},{"key":"B71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-026-02603-y","article-title":"miRNA-driven cancer cell plasticity, tolerance and therapy resistance: lessons from melanoma","volume":"25","author":"Ortolano","year":"2026","journal-title":"Mol Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/cmr.0000000000000873","article-title":"The inhibitory role of microRNA-141-3p in human cutaneous melanoma growth and metastasis through the fibroblast growth factor 13-mediated mitogen-activated protein kinase axis","volume":"33","author":"Yang","year":"2023","journal-title":"Melanoma Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3565970","article-title":"Proteomic technology \u201clens\u201d for epithelial-mesenchymal transition process identification in oncology","volume":"2019","author":"Neagu","year":"2019","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-025-02338-2","article-title":"Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025","volume":"24","author":"Allgayer","year":"2025","journal-title":"Mol Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2709275","article-title":"Exosomal miR-22-3p from mesenchymal stem cells inhibits the epithelial-mesenchymal transition (EMT) of melanoma cells by regulating LGALS1","volume":"27","author":"Chen","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/15330338221082431","article-title":"miR-498 targets UBE2T to inhibit the proliferation of malignant melanoma cells","volume":"21","author":"Cao","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70909","article-title":"CircANKRD52 augments the growth and invasion of melanoma cells by sponging miR-141-3p and upregulating PRKACB","volume":"29","author":"Chu","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27062854","article-title":"miR-374b-5p modulates melanoma progression by targeting VEGFC and regulating MAPK signaling in the tumor microenvironment","volume":"27","author":"Chen","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1691608","article-title":"Immune checkpoint inhibitors in melanoma: mechanisms, immune cell interactions, and the tumour microenvironment","volume":"16","author":"Liang","year":"2025","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.934","article-title":"Identification and characterization of novel CD274 (PD-L1) regulating microRNAs and their functional relevance in melanoma","volume":"12","author":"Vaxevanis","year":"2022","journal-title":"Clin Transl Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121765","article-title":"Novel antitumor therapeutic strategy using CD4+ T cell-derived extracellular vesicles","volume":"289","author":"Shin","year":"2022","journal-title":"Biomaterials"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1186","article-title":"MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell\u2010mediated cytolysis","volume":"13","author":"Pane","year":"2023","journal-title":"Clin Transl Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0934","article-title":"Mirc11 disrupts inflammatory but not cytotoxic responses of NK cells","volume":"7","author":"Nanbakhsh","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s10517-022-05605-0","article-title":"Hypoxia modulates melanoma cells proliferation and apoptosis via miRNA-210\/ISCU\/ROS signaling","volume":"173","author":"Suwei","year":"2022","journal-title":"Bull Exp Biol Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.2478\/aite-2026-0002","article-title":"SCARA5 induces ferroptosis to inhibit the proliferation and migration of skin melanoma cells and regulates the GPX4\/ACSL4 signaling pathway","volume":"74","author":"Zheng","year":"2025","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1015358","article-title":"Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis","volume":"13","author":"Ni","year":"2023","journal-title":"Front Oncol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12935-026-04239-w","article-title":"TMT proteomics reveals that miR-425-5p promotes proliferation and metastasis of malignant melanoma by inhibiting SCARA5","volume":"26","author":"Ni","year":"2026","journal-title":"Cancer Cell Int"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1770102","article-title":"MicroRNA-targeted reprogramming of CD8+ T cells against cancer","volume":"17","author":"Mao","year":"2026","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1826584","article-title":"Multiple roles of MicroRNAs in melanoma: biomarkers for diagnosis, prognosis, and treatment prediction","volume":"17","author":"Huang","year":"2026","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07995-w","article-title":"Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer","volume":"50","author":"Rajakumar","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030577","article-title":"Regulation of lncRNAs in melanoma and their functional roles in the metastatic process","volume":"11","author":"Melixetian","year":"2022","journal-title":"Cells"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17244033","article-title":"Silent players, loud impact: the influence of lncRNAs on melanoma progression","volume":"17","author":"Kie\u0142bowski","year":"2025","journal-title":"Cancers"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194848","article-title":"The functional role of long non-coding RNAs in melanoma","volume":"13","author":"Wozniak","year":"2021","journal-title":"Cancers"},{"key":"B94","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat Genet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1186\/s12885-020-07302-5","article-title":"Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41419-019-1620-3","article-title":"MALAT1 regulates miR-34a expression in melanoma cells","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105643","article-title":"Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours","volume":"114","author":"Ebbelaar","year":"2025","journal-title":"eBioMedicine"},{"key":"B98","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41420-024-01834-6","article-title":"SOX on tumors, a comfort or a constraint","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-026-08349-x","article-title":"The oncogenic potential of SOX12: a comprehensive and perspective view","volume":"24","author":"Leng","year":"2026","journal-title":"J Transl Med"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.3030","article-title":"SOX4 promotes melanoma cell migration and invasion though the activation of the NF-\u03baB signaling pathway","volume":"40","author":"Cheng","year":"2017","journal-title":"Int J Mol Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101448","article-title":"STAT3 and STAT5 targeting for simultaneous management of melanoma and autoimmune diseases","volume":"11","author":"Logotheti","year":"2019","journal-title":"Cancers"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114929","article-title":"The roles, molecular interactions, and therapeutic value of CDK16 in human cancers","volume":"164","author":"Wang","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2016.4321","article-title":"miR-33a is downregulated in melanoma cells and modulates cell proliferation by targeting PCTAIRE1","volume":"11","author":"Tian","year":"2016","journal-title":"Oncol Lett"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3727\/096504017x14920318811749","article-title":"The lncRNA CCAT1 upregulates proliferation and invasion in melanoma cells via suppressing miR-33a","volume":"26","author":"Lv","year":"2018","journal-title":"Oncol Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","article-title":"Translation of circRNAs","volume":"66","author":"Pamudurti","year":"2017","journal-title":"Mol Cell"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4091668","article-title":"Clinical potential of microRNA-7 in cancer","volume":"4","author":"Horsham","year":"2015","journal-title":"J Clin Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpor.2020.07.007","article-title":"cfRNAs as biomarkers in oncology \u2013 still experimental or applied tool for personalized medicine already","volume":"25","author":"Kolenda","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1339357","article-title":"Circulating miRNAs as biomarkers for the diagnosis in patients with melanoma: systematic review and meta-analysis","volume":"15","author":"Jones","year":"2024","journal-title":"Front Genet"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.7150\/thno.31502","article-title":"A comprehensive study of vesicular and non-vesicular miRNAs from a volume of cerebrospinal fluid compatible with clinical practice","volume":"9","author":"Prieto-Fern\u00e1ndez","year":"2019","journal-title":"Theranostics"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.581007","article-title":"microRNAs biogenesis, functions and role in tumor angiogenesis","volume":"10","author":"Annese","year":"2020","journal-title":"Front Oncol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142991","article-title":"Identification and comparison of exosomal and non-exosomal microRNAs in mantle tissue of Pinctada fucata (Akoya pearl oyster)","volume":"309","author":"Meng","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01500","article-title":"Non-exosomal and exosomal circulatory microRNAs: Which are more valid as biomarkers","volume":"10","author":"Nik Mohamed Kamal","year":"2020","journal-title":"Front Pharmacol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094493","article-title":"Exosomal and non-exosomal microRNAs: new kids on the block for cancer therapy","volume":"23","author":"Syed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00119","article-title":"Circulating miRNAs: cell-cell communication function","volume":"4","author":"Turchinovich","year":"2013","journal-title":"Front Genet"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.04.137","article-title":"MicroRNAs are tightly associated with RNA-induced gene silencing complexes in vivo","volume":"372","author":"Tang","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B117","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14030495","article-title":"Extracellular vesicles: a comprehensive review of their origins, functions, and therapeutic potential","volume":"14","author":"Schank","year":"2026","journal-title":"Biomedicines"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13102459","article-title":"Comparative proteomics of seminal exosomes reveals size-exclusion chromatography outperforms ultracentrifugation","volume":"13","author":"Moharana","year":"2025","journal-title":"Biomedicines"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2015.12.041","article-title":"Serum miR-16: a potential biomarker for predicting melanoma prognosis","volume":"136","author":"Guo","year":"2016","journal-title":"J Invest Dermatol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1420360","article-title":"Liquid biopsy for diagnostic and prognostic evaluation of melanoma","volume":"12","author":"Slusher","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2025.100306","article-title":"Liquid biopsy as a potential tool for diagnosis and clinical monitoring of cutaneous and uveal melanoma","volume":"14","author":"Ferraz","year":"2025","journal-title":"J Liq Biopsy"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1090","article-title":"Circulating cell\u2010free messenger RNA enables non\u2010invasive pan\u2010tumour monitoring of melanoma therapy independent of the mutational genotype","volume":"12","author":"Albrecht","year":"2022","journal-title":"Clin Transl Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12063","article-title":"Proteomic profile of melanoma cell-derived small extracellular vesicles in patients\u2019 plasma: a potential correlate of melanoma progression","volume":"10","author":"Pietrowska","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102152","article-title":"Proteomic and metabolomic profiles of plasma-derived extracellular vesicles differentiate melanoma patients from healthy controls","volume":"50","author":"Bollard","year":"2024","journal-title":"Transl Oncol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40364-025-00889-6","article-title":"Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery","volume":"14","author":"Ansermino","year":"2026","journal-title":"biomark Res Engl"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.935816","article-title":"Comprehensive analyses of miRNAs revealed miR-92b-3p, miR-182-5p and miR-183-5p as potential novel biomarkers in melanoma-derived extracellular vesicles","volume":"12","author":"Gerloff","year":"2022","journal-title":"Front Oncol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001198","article-title":"miRNA packaging into small extracellular vesicles and implications in pain","volume":"9","author":"DaCunza","year":"2024","journal-title":"Pain Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12885-024-11819-4","article-title":"Diagnostic potential of exosomal extracellular vesicles in oncology","volume":"24","author":"Andre","year":"2024","journal-title":"BMC Cancer"},{"key":"B130","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12935-021-02164-8","article-title":"The plasma exosomal mir-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma","volume":"21","author":"Guo","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1180799","article-title":"A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients","volume":"10","author":"De Martino","year":"2023","journal-title":"Front Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3390\/ph19060913","article-title":"Immunosuppressive pathways in cutaneous melanoma: functional integration between PD-1 and CD73 and therapeutic implications","volume":"19","author":"Bertolucci","year":"2026","journal-title":"Pharmaceuticals"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1002551","article-title":"Mechanisms of extracellular vesicle-mediated immune evasion in melanoma","volume":"13","author":"Dieterich","year":"2022","journal-title":"Front Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"14482","DOI":"10.1038\/s41598-019-50848-z","article-title":"Extracellular vesicles shedding promotes melanoma growth in response to chemotherapy","volume":"9","author":"Andrade","year":"2019","journal-title":"Sci Rep"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1172\/jci98060","article-title":"Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma","volume":"128","author":"Huber","year":"2018","journal-title":"J Clin Invest"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.03.050","article-title":"Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine\/autocrine signaling in the tumor microenvironment","volume":"376","author":"Xiao","year":"2016","journal-title":"Cancer Lett"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13512","article-title":"Tumor\u2010derived exosomes enriched by miRNA\u2010211a promote antitumor immune response in B16F10 tumor-bearing mice","volume":"133","author":"Ataollahi","year":"2025","journal-title":"APMIS"},{"key":"B138","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41419-026-08597-1","article-title":"Melanoma exosomal miR-708-5p promotes macrophage M2 polarization and cancer metastasis","volume":"17","author":"Xu","year":"2026","journal-title":"Cell Death Dis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116791","article-title":"miR-466f-3p promotes pro-inflammatory activation of macrophages through NF-\u03baB signaling and suppresses melanoma metastasis","volume":"182","author":"Katayama","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041074","article-title":"Extracellular vesicles in cancer drug resistance: implications on melanoma therapy","volume":"15","author":"Musi","year":"2023","journal-title":"Cancers"},{"key":"B141","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/1061186x.2022.2114000","article-title":"Role of exosomes in tumour growth, chemoresistance and immunity: state-of-the-art","volume":"31","author":"Hosseinikhah","year":"2023","journal-title":"J Drug Target"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020464","article-title":"Melanoma-derived exosomal miR-125b-5p educates tumor associated macrophages (TAMs) by targeting lysosomal acid lipase A (LIPA)","volume":"12","author":"Gerloff","year":"2020","journal-title":"Cancers"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2018.08.030","article-title":"Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo","volume":"371","author":"Zhou","year":"2018","journal-title":"Exp Cell Res"},{"key":"B144","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00262-025-04145-6","article-title":"Cytotoxic CD4+ T cells exhibit an immunosuppressive shift in checkpoint immunotherapy resistance in melanoma patients","volume":"74","author":"Bae","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt4551","article-title":"B cell extracellular vesicles influence melanoma response to immune checkpoint therapy","volume":"11","author":"Al Hrout","year":"2025","journal-title":"Sci Adv"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031737","article-title":"miRNAs related to immune checkpoint inhibitor response: a systematic review","volume":"25","author":"Garc\u00eda-Gim\u00e9nez","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12967-022-03668-1","article-title":"A novel microRNA signature for the detection of melanoma by liquid biopsy","volume":"20","author":"Sabato","year":"2022","journal-title":"J Transl Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s43856-026-01629-z","article-title":"Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma","volume":"6","author":"Splendiani","year":"2026","journal-title":"Commun Med"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17081281","article-title":"Predictive factors for sentinel lymph node positivity in melanoma patients-the role of liquid biopsy, microRNA and gene expression profile panels","volume":"17","author":"Venturi","year":"2025","journal-title":"Cancers"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091688","article-title":"Association of miR-146a-5p and miR-21-5p with prognostic features in melanomas","volume":"16","author":"Naddeo","year":"2024","journal-title":"Cancers"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113361","article-title":"A pilot study comparing the efficacy of lactate dehydrogenase levels versus circulating cell-free microRNAs in monitoring responses to checkpoint inhibitor immunotherapy in metastatic melanoma patients","volume":"12","author":"Bustos","year":"2020","journal-title":"Cancers"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116659","article-title":"Keratinocyte-derived exosomal miR-31-5p reduces vemurafenib sensitivity in melanoma cells","volume":"179","author":"Li","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18050792","article-title":"m6A RNA methylation promotes the melanoma metastasis mediated by extracellular vesicle miR-23a-5p","volume":"18","author":"Li","year":"2026","journal-title":"Cancers"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14153706","article-title":"Circulating mir-1246 and mir-485-3p as promising biomarkers of clinical response and outcome in melanoma patients treated with targeted therapy","volume":"14","author":"Levati","year":"2022","journal-title":"Cancers"},{"key":"B156","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12967-025-06941-1","article-title":"Development of an innovative duplex digital PCR assay for circulating MiRNA ratio quantification in metastatic melanoma","volume":"23","author":"De Gregorio","year":"2025","journal-title":"J Transl Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-25-1927","article-title":"Game-Set-MATCH: Liquid biopsy advances to the next round","volume":"31","author":"Russo","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12391","article-title":"Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma","volume":"13","author":"Calapre","year":"2019","journal-title":"Mol Oncol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","article-title":"Detection of circulating tumor DNA in early- and late-stage human malignancies","volume":"6","author":"Bettegowda","year":"2014","journal-title":"Sci Transl Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1078-0432.ccr-25-0430","article-title":"The impact of concordance between liquid and tissue biopsy for actionable mutations: insights from the ROME trial","volume":"32","author":"Botticelli","year":"2026","journal-title":"Clin Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-025-02298-7","article-title":"Circulating microRNAs: functional biomarkers for melanoma prognosis and treatment","volume":"24","author":"Lim","year":"2025","journal-title":"Mol Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12885-023-10891-6","article-title":"Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Cancer"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i19.2930","article-title":"Expression and predictive value of miR-489 and miR-21 in melanoma metastasis","volume":"7","author":"Mo","year":"2019","journal-title":"World J Clin cases"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2017.5","article-title":"Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing","volume":"97","author":"Babapoor","year":"2017","journal-title":"Lab Invest"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082111","article-title":"MicroRNA-21-enriched exosomes as epigenetic regulators in melanomagenesis and melanoma progression: the impact of Western lifestyle factors","volume":"12","author":"Melnik","year":"2020","journal-title":"Cancers"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.12.010","article-title":"The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker","volume":"61","author":"Kanemaru","year":"2011","journal-title":"J Dermatol Sci"},{"key":"B167","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12967-016-0811-2","article-title":"Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma","volume":"14","author":"Felicetti","year":"2016","journal-title":"J Transl Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"12687","DOI":"10.1038\/s41598-026-43556-y","article-title":"Blood-based circulating microRNAs as diagnostic biomarkers in cutaneous melanoma: a systematic review and meta-analysis","volume":"16","author":"Pramono","year":"2026","journal-title":"Sci Rep"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2538","article-title":"The promyelocytic leukemia zinc finger-microRNA-221\/-222 pathway controls melanoma progression through multiple oncogenic mechanisms","volume":"68","author":"Felicetti","year":"2008","journal-title":"Cancer Res"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.12659\/msm.891327","article-title":"Circulating miR-221 expression level and prognosis of cutaneous malignant melanoma","volume":"20","author":"Li","year":"2014","journal-title":"Med Sci Monit"},{"key":"B171","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.omto.2019.11.001","article-title":"miR-489-3p\/SIX1 axis regulates melanoma proliferation and glycolytic potential","volume":"16","author":"Yang","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2012.62","article-title":"Loss of microRNA-205 expression is associated with melanoma progression","volume":"92","author":"Liu","year":"2012","journal-title":"Lab Invest"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3661","article-title":"Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer","volume":"6","author":"Margue","year":"2015","journal-title":"Oncotarget"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12343","article-title":"MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis","volume":"28","author":"Tembe","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-14-2566","article-title":"A miRNA-based signature detected in primary melanoma tissue predicts development of brain metastasis","volume":"21","author":"Hanniford","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbrc.2019.05.111","article-title":"MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect","volume":"515","author":"Yang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176183","article-title":"Tumor suppressor role of hsa-miR-193a-3p and -5p in cutaneous melanoma","volume":"21","author":"Polini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B178","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-018-0819-8","article-title":"Loss of miR-204 expression is a key event in melanoma","volume":"17","author":"Galasso","year":"2018","journal-title":"Mol Cancer"},{"key":"B179","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41388-022-02547-9","article-title":"Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance","volume":"42","author":"Fattore","year":"2023","journal-title":"Oncogene"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116165","article-title":"The regulatory mechanisms of oncomiRs in cancer","volume":"171","author":"Otmani","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050459","article-title":"Relationship between circulating and tissue microRNAs in a murine model of breast cancer","volume":"7","author":"Waters","year":"2012","journal-title":"PloS One"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.3390\/cells9041044","article-title":"Sorting mechanisms for microRNAs into extracellular vesicles and their associated diseases","volume":"9","author":"Groot","year":"2020","journal-title":"Cells"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.3390\/epigenomes7020009","article-title":"Critical considerations for investigating microRNAs during tumorigenesis: a case study in conceptual and contextual nuances of miR-211-5p in melanoma","volume":"7","author":"Vand-Rajabpour","year":"2023","journal-title":"Epigenomes"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1637958","article-title":"Clinical development prospects of siRNA drugs for tumor therapy: analysis of clinical trial registration data from 2004 to 2024","volume":"16","author":"Wang","year":"2025","journal-title":"Front Pharmacol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0131","article-title":"Evidence-based procedures to improve the reliability of circulating miRNA biomarker assays","volume":"62","author":"Greytak","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14515","article-title":"MiR-423-5p is a novel endogenous control for the quantification of circulating miRNAs in human esophageal squamous cell carcinoma","volume":"9","author":"Guo","year":"2023","journal-title":"Heliyon"},{"key":"B188","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/2211536607666180709143335","article-title":"The influence of pre-analytical factors on the analysis of circulating microRNA","volume":"7","author":"Shiotsu","year":"2018","journal-title":"MicroRNA"},{"key":"B189","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2215\/cjn.0000000000000458","article-title":"A randomized controlled clinical trial testing effects of Lademirsen on kidney function decline in adults with Alport syndrome","volume":"19","author":"Gale","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18152497","article-title":"Targeting lncRNAs to overcome cancer therapy resistance: advances in RNA therapeutics and delivery strategies","volume":"8","author":"Drosos","year":"2026","journal-title":"Cancers"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12363","article-title":"Inhibition of extracellular vesicle-derived miR-146a-5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes","volume":"12","author":"Rigg","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B193","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12964-020-00601-1","article-title":"miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators","volume":"18","author":"Vergani","year":"2020","journal-title":"Cell Commun Signal"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-1397","article-title":"miR-146a controls immune response in the melanoma microenvironment","volume":"79","author":"Mastroianni","year":"2019","journal-title":"Cancer Res"},{"key":"B195","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41419-025-08091-0","article-title":"HypoxamiRs: the hidden architects of tissue adaptation in hypoxia","volume":"16","author":"Egea","year":"2025","journal-title":"Cell Death Dis"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0504","article-title":"MicroRNA-155 expression is enhanced by T-cell receptor stimulation strength and correlates with improved tumor control in melanoma","volume":"7","author":"Martinez-Usatorre","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B197","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s13046-018-0911-3","article-title":"Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway","volume":"37","author":"Zhou","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1173035","article-title":"CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients","volume":"14","author":"Vaddi","year":"2023","journal-title":"Front Immunol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12026-021-09247-8","article-title":"Host miRNA and immune cell interactions: relevance in nano-therapeutics for human health","volume":"70","author":"Sharma","year":"2022","journal-title":"Immunol Res"},{"key":"B200","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00253-025-13620-0","article-title":"MiRNA-based drugs: challenges and delivery strategies","volume":"109","author":"Wang","year":"2025","journal-title":"Appl Microbiol Biotechnol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2025.100556","article-title":"Exploring the therapeutic potential of microRNAs: targeted gene regulation strategies for enhanced cancer therapy","volume":"23","author":"Pandey","year":"2025","journal-title":"J Genet Eng Biotechnol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6c04991","article-title":"Site-specifically modified circular ribonucleic acid serves as multitarget miRNA sponge with low immunogenicity","volume":"148","author":"Pan","year":"2026","journal-title":"J Am Chem Soc"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10731","article-title":"miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1111\/bph.17302","article-title":"Mitigating off-target effects of small RNAs: conventional approaches, network theory and artificial intelligence","volume":"182","author":"Bereczki","year":"2025","journal-title":"Br J Pharmacol"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01114-x","article-title":"MicroRNAs in oncology: a translational perspective in the era of AI","volume":"23","author":"Jurj","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.3390\/dermatopathology12030031","article-title":"Molecular and genetic markers for malignant melanoma: implications for prognosis and therapy","volume":"12","author":"Fleshner","year":"2025","journal-title":"Dermatopathology"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3390\/cells14181476","article-title":"Next-Generation mRNA vaccines in melanoma: advances in delivery and combination strategies","volume":"14","author":"Zoroddu","year":"2025","journal-title":"Cells"},{"key":"B208","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3892\/mmr.2021.12217","article-title":"COVID 19 vaccination and IgG and IgA antibody dynamics in healthcare workers","volume":"24","author":"Zurac","year":"2021","journal-title":"Mol Med Rep"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.3390\/cells15020099","article-title":"Advances in mRNA-based melanoma vaccines: a narrative review of lipid nanoparticle and dendritic cell delivery platforms","volume":"15","author":"Sisk","year":"2026","journal-title":"Cells"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2026.120879","article-title":"Non-coding RNAs as emerging biomarkers in melanoma","volume":"585","author":"Abuhassan","year":"2026","journal-title":"Clin Chim Acta"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.05.011","article-title":"The prognostic and predictive value of melanoma-related microRNAs using tissue and serum: a microRNA expression analysis","volume":"2","author":"Stark","year":"2015","journal-title":"EbioMedicine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1949578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:03:54Z","timestamp":1791194634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1949578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":211,"alternative-id":["10.3389\/fimmu.2026.1949578"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1949578","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1949578"}}